ENG

  • Liqiong WANG

    Equity Partner / Shanghai

  • Tel +86-21-6061-3666

    Email liqiongwang@zhonglun.com

  • Practices

    Hong Kong & Overseas Capital Markets, Chinese Mainland Capital Markets, Private Equity & Investment Funds

  • Industries

    Real Estate, Transportation & Logistics, Healthcare, Pharmaceuticals & Life Sciences, Education & Training

CV

Liqiong WANG

Ms. Wang has provided legal services for dozens of international large-scale investments and M&A projects in the industries of real estate, logistics, IT, pharmacy, medical instruments, food, catering, TMT, electronics, construction, textiles and clothing, education, energy, etc. and has extensive experiences in representing a dozen of domestic enterprises in overseas listing projects. Ms. Wang is currently the legal consultant for China Eastern Air Logistics Co., Ltd., CITIC, SinoMab BioScience and several reputable companies. Meanwhile, Ms. Wang has also provided legal consulting services for and is advising a number of enterprises in the listing at the PRC A-Share Stock Exchange (including Main Board, SSE STAR Market, ChiNext of SZSE, and Beijing Stock Exchange) and foreign stock exchange (including in the US, Singapore, Australia and Hong Kong) in the industries of biopharmaceutical and healthcare, new energy, software, finance, leasing, e-commerce, internet, information technology, construction, film and television production, chemical, special equipment production, telecommunication, mobile games, etc.

Representative Matters

Overseas and Chinese Mainland Capital Market

Acted as PRC legal counsel for the underwriter in the listing of Adlai Nortye Ltd. (ANL) on the Nasdaq Global Market

Acted as PRC legal counsel for the underwriter in the secondary listing of Comba Telecom Systems Holdings Limited (STC) on the Mainboard of Singapore Exchange Securities Trading Limited

Acted as legal counsel for Kunshan Asia Aroma Corp., Ltd. (301220) in its listing on the ChiNext of the Shenzhen Stock Exchange

Acted as PRC legal counsel for SinoMab BioScience Limited (3681.HK) in its listing on the Mainboard of HKEX

Acted as PRC legal counsel for Powerbridge Technologies Co., Ltd. (PBTS) in its listing at NASDAQ

Advised a state-owned forestry in nearly EUR 400 million (equal) foreign currency bond issue at Frankfurt Stock Exchange

Advised OEL (Holdings) Limited, an SGX-listed company, in acquisition of a domestic oil field asset

Advised Singapore LIONHUB in RTO of an Australian listed company by private equity placement of domestic real estate program

Advised JLJ Holdings Limited in its listing at SGX

Advised Man Wah Holdings Limited, an SGX-listed company, in private placement for the acquisition of King Famous Bedding Co., Ltd.

Advised Shanghai Zizhu Digital Information Co. Limited in CNY 280 million SME private debt program at Shanghai Stock Exchange

Advised Fujian Guanfu Modern Home-Use Company, a listed company at SME Board, in non-public offering stock project

Advised Reyphon Agriceutical Limited in its listing at SGX

Advised Assetgold Finance Limited on its RTO listing at SGX

Advised Fujian Zhenyun Plas Ind Co., Ltd. in its listing at SGX

Advised Oriental Century Limited in its listing at SGX

Advised FerroChina Limited in its listing at SGX

Advised YAAN Security Technology Limited in its listing at SGX

Advised Junma Tyre Cord Company Ltd in its listing at SGX

Advised ACE Achieve Infocom Limited in its listing at SGX

Advised Youcan Foods International Limited in its listing at SGX

Advised Oriental Food (Holdings) Limited in its listing at SGX

Advised 8 Telecom International Holdings Limited in its listing at SGX

Advised China Petrotech Holdings Limited in its listing at SGX

Advised United Envirotech Limited in its listing at SGX

Advised Celestial NutriFoods Limited on its listing at SG

Advised Beauty China Holdings Limited in its listing at SGX

Advised Sinomen Technology Limited in its listing at SGX

Advised China Cast Communication Holdings Limited in its listing at SGX

Advised Hyflux Limited in its listing at SGX

Advised Europtronic Group Ltd in its listing at SGX

Advised LANKOM Electronics Limited in its listing at SGX

Advised Radiance Electronics Limited in its listing at SGX

Advised Asia Environment Holdings Limited in its listing at SGX

Advised Tianjin Zhong Xin Pharm Group in its listing at SGX

Advised Eagle Brand Holdings Limited in its listing at SGX (the first “Red Chip Shares” listing in Singapore by a PRC company)

Advised on dozens of restructuring, private placement and OTC listing projects

 

Private Equity & Investment Funds and M&A

Advised Apricot Capital in its formation of Suzhou Xingze Xingyong Emerging Medical Industry Equity Investment Fund Management Partnership (LP)

Advised Fosun Health Capital in its Series A investment in Starmab Biologics (Suzhou) Co., Ltd.

Advised Shanghai Quanray Electronics Co., Ltd. in its Series D financing

Advised Apricot Capital Fund IV in its angel round investment in Lingtai Tianrun Biotechnology (Shanghai) Co., Ltd.

Advised Asia Aroma (301220) in its investment projects

Advised Apricot Capital, a well-known investment fund, in various investment projects in pharmaceutical industry including medical instruments, drug R&D, genome editing, sports medicine, etc.

Advised Paper Games, a well-known mobile gaming company, in its investment projects

Advised a data security technology company, founded by a group of network security professionals, in its several financing projects

Advised Apricot Capital in its investments in Shine Yo Medical (Series A) and United InnoMed (Cayman) Limited (Series A+)

Advised MediLink Therapeutics in its series A1 and series A2 financing

Advised Evopoint Biosciences in its series C and series D financing

Advised SinoMab, a Hong Kong listened company (3681.HK), and Apricot Capital in their joint investment in a newly built company focusing on genomics-based target release and drug development

Advised Exegenesis Bio Inc. in its series A financing

Advised Adlai Nortye in several financing projects

Advised Achelois in its establishment and early financing project

Advised Apricot Capital in its leading investment in a company dedicated to R&D of medical devices

Advised Ningbo Xinghang Capital in its investment in a medical device company dedicated to cardiovascular pre-hospital care products

Advised an innovative biopharmaceutical company based in Chengdu in its angel round financing

Advised a medicine service platform in its establishment and financing

Advised a precision cancer medicine service platform in its overseas financing

Advised a drug discovery and development company focusing in liver diseases, on its financing project

Advised Hepu Pharmaceutical in several financing projects

Advised Paper Games in its sole investment in Star-Linear

Advised Chip Eng Seng Group, a Singapore-listed company, and HaiYi Group in the acquisition of a real estate company in Taicang

Advised Heguru in its overseas equity transfer and establishment of a joint venture with domestic investors

Advised Eastern Air Logistics Co., Ltd. in its establishment of global branches and proposed listing at A-Share Stock Exchange

Advised CITIC City Development Fund in its investment in Taiyuan Project

Advised CITIC City Construction and Development Ltd. in its investment in Taizhou Phoenix Manor Project

Advised CITIC City Development Fund in its investment in Kunshan Federation Gardens Project

Advised CMIA in its investment in Wellbright

Advised Singapore private fund in its investment in the domestic project of aquiculture and caviar processing

Advised China-LAC Cooperation Fund in its acquisition of Jamaica aluminum asset project from China JiuGang Group

Advised in USD 200 million investment by a fund controlled by GSH, a Singpaore-listed company, to a PRC logistics company

Advised in financing project of Champion Technology Holdings Limited, a Hong Kong listed company

Advised in acquisition of Shanghai Community International School

Advised in investment, M&A and legal consultant services for Metro Education (wholly owned by DINGLI CORP. , LTD (300050))

Advised in investments and proposed exits by Yulong/Da Hang Investment Fund

Advised in restructuring and reorganization of a large store chain operator

Advised in investment in the medical beauty industry by the first RMB equity investment fund controlled by OCBC

Advised in equity restructuring of Wuxi Yiren Cancer Hospital

Advised a high-end health checkup center in its sales of whole equity interest to iKang Guobin Healthcare Group, Inc.

Advised in registration of private equity fund managers and major amendments for multiple funds, including CMIA, Zhiji Investment, etc.

Advised in establishment of a sino-lease financing company in Chongqing by two SGX-listed companies (MoneyMax and AP Oil) together with Chongqing Zongshen Power Machinery Co., Ltd.

Advised Banyan Tree China in domestic restructuring project

Advised Shanghai Qin Lian Holdings Limited in acquisition of Aoqili Limited (Tianqi Toothpaste) and its associated assets

Advised in cooperative program of China Eastern Airlines and China Airlines in relation to VIP lounge of an international airport

Advised in joint-stock reform program of Clearing Center for City Commercial Banks (CCFCCB)

Advised Jiangxi Copper Corporation (600362.SH) in acquisition of the entire office building of Shanghai Poly Plaza

Advised China Eastern Airlines Corporation Limited (600115) in restructuring program of freight and logistics business

Advised JCC International Trade Limited in private equity placement and joint-stock reform

Advised Poly Real Estate and Greenland Holdings Group in real estate cooperative development project in Shanghai

Advised in Jiangsu Zeversolar New Energy Co., Ltd.’s sales of 72.5% equity interest to SMA Solar Technology AG

Advised in Cathay Capital Private Equity’s equity investment on the projects of Beijing/ Dongguan toy production and sales

Advised in establishment of Changzhou, Changsha Branches and capital increment by Shanghai Orient Securities Futures Co. Ltd

Advised Shanghai Sugar Cigarette & Wine Group in shares increment on Shanghai JinFeng Wine Company

Advised in shares transfer over TianAn Insurance Company by Lujiazui Group, Jinqiao Group and Waigaoqiao Group

Advised Startech Electronics Ltd, an SGX-listed company, in acquisition of the entire issued and paid-up share capital of Red Flag Holdings Co., Ltd

Advised an US large-scale investment institution, headed by Sequoia Capital in investment into a PRC forestry enterprise

Advised a group of overseas investors in their investment in an overseas proposed listing company which owns a power equipment and device manufacturer in Sichuan by way of subscription in the proposed listco

Acted as PRC legal counsel for PRC region in Volvo's global acquisition on Ingersoll-Rand

Advised Century 21 China in acquisition of Bonity Property Group

Advised a group of international investors in their investment in one of the largest solar energy projects in China by way of subscription in China Sunergy Limited

Advised Sequoia China Capital, IDG Technology Venture Investment, CDH Net, GMO Venture Partners and other venture investors in their investments in Young Vision Group Limited (an overseas holding company in relation to “Qihoo 奇虎”)

Advised Sequoia Capital and a group of international investors in co-acquisition of an aggregate of USD 400 million preference shares in Shui On Land Limited

Advised international investors in acquisition of 70% equity interests in Shanghai Xin Mao Property Development Co. Ltd., a subsidiary of Singapore CapitaLand Limited

Advised Singapore Capital and Retail Limited in acquisition of operation and leasing right of Dragon Mall located at Minhang District, Shanghai

Advised Henderson Global Investors (Singapore) Limited in its acquisition of the equity interest in Airmate Cayman International Limited

Advised Lion Asiapac Limited in the large acquisition of 15 commercial companies under the control of Parkson and 17 brewery production companies under the control of Lion Asiapac in PRC

Advised Singapore NatSteel Limited, an SGX-listed company, in its investments and cooperation projects within Shanghai and Jiangsu Province, PRC

Advised Singapore Parkway Group in its investments and cooperation projects in the PRC

Advised Hongguo International Limited, an SGX-listed company, in its subsidiary's acquisition of an agent in Nanjing, PRC

Advised China Aviation Oil (Singapore) Corporation Limited, an SGX-listed company, in the acquisition of 33% interest in Shanghai Pudong International Airport Aviation Fuel Supply Company Ltd

Advised Qingbai Group in the property development project in Shenyang PRC

Advised China Bank of Industry and Commerce Singapore Branch and Guangdong Province Bank Singapore Branch in their loan facility project

Advised Sengled, Kunshan Asia Aroma, Paper Games, Evopoint Biosciences, etc., in their employee equity incentives before listing at A-Share Stock Exchange

Advised JINYOU Fluorine Materials, GENTECH Industries, Daoxila, Kronoswiss, United Cell Biotechnology, Quanray Electronics, etc. in their conversion and employee equity incentives for listing purpose

Related

  • Bar Admissions/Professional Qualifications

    PRC Bar

  • Education

    EMBA, China Europe International Business School (CEIBS)
    LL.B. in Economic Law, Jiangsu University

  • Professional Experience

    Partner, Zhonglun Law Firm, 2014 to present
    Senior Partner, Zhenghan Law Firm, 2007-2014
    Partner, Shanghai Capitallaw & Partner, 2005-2007
    China Law Advisor, WongPartnership LLP, 2003-2005
    Foreign Legal Counsel, Singapore Shook Lin & Bok, 1997-2003
    Associate, Fujian Shi Tong Law Office, 1993-1997
    Legal Counsel, Fujian Jianzhuang Science & Technology Development Co., Ltd (PRC)., 1992-1993

  • Languages

    Chinese
    English